Articles On Paragon Care (ASX:PGC)

The Vanguard Australian Shares Index ETF (ASX: VAS) is trading for $104.59 per unit, up 1.15% at the time of writing on Friday. This popular ASX exchange-traded fund (ETF) seeks to track the S&P/ASX 300 Index (ASX: XKO) before fees....

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Highlights Amotiv positioned as a resilient player in the automotive sector Temple & Webster shows strong growth in the homewares segment Paragon Care gaining market share in healthcare services Amotiv, formerly known as GUD...

Control Bionics says it has overcome the “challenges” of the 2023-24 year Ord Minnett identifies the health sector stunners Noxopharm finds a drug manufacturer to kick-start its lupus trial   Health Check is renowned biotech journo Tim Bo...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMed...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin New research on the Pharmaceutical Wholesaling sector identifies three stocks with l...

The ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biotechs in June were Actinogen, Optiscan and EZZ Life Science, amongst others    The S&P/ASX 200 Health Care index [XHJ] saw a 4% increase...

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

Momentum trading involves taking advantage of, and making profits from, upward trends in a stock. The strategy makes a calculated bet that the stock market’s recent winners will remain winners. The Relative Strength Index (RSI) is a popular...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

The DroneShield Ltd (ASX: DRO) share price is on the move again on Thursday. In morning trade, the counter drone technology company's shares were up as much as 9% to 75.5 cents. However, its shares have since pulled back and are now tradin...

It has been another busy week for Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX sh...

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

The S&P/ASX 200 Index (ASX: XJO) is having a poor session on Wednesday. In afternoon trade, the benchmark index is down 0.25% to 7,705.2 points. Four ASX shares that are not letting that hold them back are listed below. Here's why th...

Have you been keeping an eye on the resurgent ASX gold rush? Or perhaps you've already joined in. If you did catch the fast-spreading gold fever and bought S&P/ASX 200 Index (ASX: XJO) gold shares five days ago, you should be sitting...

It was another bumpy but unsuccessful day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Tuesday. Today's trading saw the ASX 200 swing between...

The ASX 200 traded sideways on Tuesday, closing the day flattish as gains in healthcare stocks were offset by losses in other sectors. Source: Market Index  Healthcare gained after the Albanese government approved an increase in private hea...

Medical equipment maker ParagonCare (ASX: PGC) has announced a “transformative” merger with CH2 Holdings to create a premier healthcare wholesaler, distributor and manufacturer operating across growing markets in the Asia Pacific region. Th...

Motley Fool Australia Chief Investment Officer Scott Phillips joined Natalia Cooper for Nine's Late News on Monday night to discuss falling building approvals and the challenges facing the economy as businesses destock, putting pressure on...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is edging higher. At the time of writing, the benchmark index is up slightly to 7,740.6 points. Four ASX shares that are rising more than most today are listed below. Here's why they...

Well, earnings season is over for another six months. And there was a lot to take in. (Quick plug: Members of Motley Fool services can expect some additional video content on earnings season over the next few weeks, so stay tuned!) But one...

4DMedical Ltd (ASX: 4DX) shares are having another positive session. At one stage today, the ASX healthcare stock was up as much as 7.5% to 78 cents. When its shares hit that level, it meant they were up 12% in the space of just two days....

Paragon Care Ltd (ASX: PGC) shares are taking off on Tuesday after returning from a trading halt. At the time of writing, the ASX small cap stock is up 27% to 26 cents. Why is this ASX small cap stock rocketing? Investors have been fightin...

Healius Ltd (ASX: HLS) shares are storming higher on Tuesday morning. In early trade, the beaten-up ASX 200 stock is up 14% to $1.28. Why is this ASX 200 stock jumping? Investors have been buying the healthcare company's shares this mornin...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ — AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited (ASX: PGC), a premier provider of healthcare...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

  Stocks settled lower on Thursday as investors remain cautious ahead of key jobs data on Friday that could determine the next move for interest rates. The Dow Jones Industrial Average closed down 10 points, or 0.03 per cent. The S&P 50...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

  Stocks fell Friday as investors wrapped up a volatile week ahead of the Federal Reserve’s policy meeting. The Dow Jones Industrial Average slid 288.87 points, or by 0.83 per cent, to 34,618.24. At its lows, the index completely wiped out...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AIM)) - Ai-Media Technologies ((AMI)) - Aurelia Metals ((BXB)) - Brambles ((C79)) - Chrysos ((CYG)) - Coventry Group ((DDR)) - Dicker Data ((EML)) - E...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market. by Tim Boreham ASX Code: ((IDT)) Share price: 6.7 cents Shares on issue: 351,337,149 Market cap: $23.5m Chief ex...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

World Overnight SPI Overnight 7360.00 – 39.00 – 0.53% S&P ASX 200 7450.70 + 40.30 0.54% S&P500 4576.73 – 12.23 – 0.27% Nasdaq Comp 14283.91 – 62.11 – 0.43% DJIA 35630.68 + 71.15 0.20% S&P500 VIX 13.93 + 0.30 2.20%...

World Overnight SPI Overnight 7383.00 + 25.00 0.34% S&P ASX 200 7410.40 + 6.80 0.09% S&P500 4588.96 + 6.73 0.15% Nasdaq Comp 14346.02 + 29.37 0.21% DJIA 35559.53 + 100.24 0.28% S&P500 VIX 13.63 + 0.30 2.25% US 10...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...